Crystalline forms of MNK inhibitors

The present invention provides crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione:The crystalline compounds of the present application are inhibitors of Mnk and finds utility in any number of therapeutic applications, incl...

Full description

Saved in:
Bibliographic Details
Main Authors Ernst, Justin T, Reich, Siegfried H, Webber, Stephen E, Xiang, Alan X, Borer, Bennett C, Sperry, Samuel, Wilson, Jo Ann Z, Sprengeler, Paul A
Format Patent
LanguageEnglish
Published 28.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione:The crystalline compounds of the present application are inhibitors of Mnk and finds utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.
AbstractList The present invention provides crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione:The crystalline compounds of the present application are inhibitors of Mnk and finds utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.
Author Borer, Bennett C
Sprengeler, Paul A
Xiang, Alan X
Reich, Siegfried H
Webber, Stephen E
Wilson, Jo Ann Z
Ernst, Justin T
Sperry, Samuel
Author_xml – fullname: Ernst, Justin T
– fullname: Reich, Siegfried H
– fullname: Webber, Stephen E
– fullname: Xiang, Alan X
– fullname: Borer, Bennett C
– fullname: Sperry, Samuel
– fullname: Wilson, Jo Ann Z
– fullname: Sprengeler, Paul A
BookMark eNrjYmDJy89L5WRQdi6qLC5JzMnJzEtVSMsvyi1WyE9T8PXzVsjMy8hMyizJLyrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxocGGhobGBuam5k5GxsSoAQCxVygV
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11130757B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11130757B23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:02:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11130757B23
Notes Application Number: US201916661507
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210928&DB=EPODOC&CC=US&NR=11130757B2
ParticipantIDs epo_espacenet_US11130757B2
PublicationCentury 2000
PublicationDate 20210928
PublicationDateYYYYMMDD 2021-09-28
PublicationDate_xml – month: 09
  year: 2021
  text: 20210928
  day: 28
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies eFFECTOR Therapeutics Inc
RelatedCompanies_xml – name: eFFECTOR Therapeutics Inc
Score 3.3538876
Snippet The present invention provides crystalline solids of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Crystalline forms of MNK inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210928&DB=EPODOC&locale=&CC=US&NR=11130757B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6Lzg4rStyJkXZs-FKFpy1DaDbfK3kbTNKw-dGOtiP-9l9I5X_QtJHBJDn73kcvdATwISvKMEmGkUpoqzMgNng0sQwpnwKVtOSRTucNRbI0S83k-nHfgfZsL09QJ_WyKIyKiMsR73cjr9e4Ry2_-VlaPvMCp1VM4c3299Y7Rf3EI1X3PDSZjf8x0xtxkqsevruqojtrR9lBc76EZbSs0BG-eykpZ_1Yp4THsT5BaWZ9AJy97cMi2ndd6cBC1AW8cttirTuGebb7QlFM1tHNNmZqVtpJaFL9oRbkseKHa5pzBXRjM2MjA3RY_V1sk093BBufQRZc_vwBtaKeSZHZmCrRwuDA5TaUjuEVF7nAuySX0_6bT_2_xCo4Um9SPB0KvoVtvPvIbVKs1v2348Q3fzn0K
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTkXnV0XpWxGyrh8PRVi7Mt3aDdfK3krTJKw-dGOtiP-9l7I5X_QtJHBJDn73kcvdATwwi_DMIkxLhdBlmJFqNOsammB2lwrTsEkmc4eD0BjG-su8N2_A-zYXpq4T-lkXR0REZYj3qpbXq90jllf_rSwfaY5Tyyc_cjx14x2j_2ITS_X6zmA68Sau6rpOPFPDV0d2VEftaPZRXO-hiW1KNAze-jIrZfVbpfhHsD9FakV1DA1etKHlbjuvteEg2AS8cbjBXnkC9-76C005WUObK9LULJWlUIJwpOTFIqe5bJtzCnf-IHKHGu6W_FwtiWe7g3XPoIkuPz8HpWemgmRmpjO0cCjTqZUKm1HDYtymVJAL6PxNp_Pf4i20hlEwTsbP4egSDiXL5O8HYl1Bs1p_8GtUsRW9qXnzDedef_0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Crystalline+forms+of+MNK+inhibitors&rft.inventor=Ernst%2C+Justin+T&rft.inventor=Reich%2C+Siegfried+H&rft.inventor=Webber%2C+Stephen+E&rft.inventor=Xiang%2C+Alan+X&rft.inventor=Borer%2C+Bennett+C&rft.inventor=Sperry%2C+Samuel&rft.inventor=Wilson%2C+Jo+Ann+Z&rft.inventor=Sprengeler%2C+Paul+A&rft.date=2021-09-28&rft.externalDBID=B2&rft.externalDocID=US11130757B2